Skip to main content

Table 3 Clinic pathological characteristics of tumors from individuals carrying the BRCA1 mutation c.2900_2901 dupCT (p.Pro968Leufs)

From: Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

Family.individual

Sex

Age

Tumor

Histopathology

Stage

Grade

ER

PgR

HER2

42.1

F

52

Ov

Endometrioid

IIIC

-

-

-

-

42.5

F

82

Ov

Serous

IIIC

-

-

-

-

72.1

F

54

Ov

Undifferentiated/Mucinous

IC

3

-

-

-

72.2

F

33

Br

Undifferentiated

IIIA

3

Neg

Neg

Neg

215.1

F

41

Ov

Serous

IIIC

3

-

-

-

263.1

F

56

Ov

Serous

IIIB

2

-

-

-

458.1

F

43

Br

IDC

II

3

Neg

Neg

Neg

458.2

F

51

Br

IDC

III

3

Neg

Neg

Neg

572.1

F

41

Ov

Serous

IIIC

-

-

-

-

704.1

F

49

Br

IDC

IIIA

-

Neg

Neg

-

828.1

F

48

Br

IDC

I

-

Pos

Pos

-

  

78

Br

IDC

IA

3

Pos

Pos

Neg

828.2

F

42

Br

IDC

IIA

3

Pos

Pos

-

828.3

F

45

Ov

-

-

-

-

-

-

  1. Age age of cancer diagnosis, F female, Br breast cancer, Ov ovarian cancer, IDC invasive ductal carcinoma, ER estrogen receptor status, PR progesterone receptor status, Her2 Her2Neu status, - not applicable or no data, Neg negative, Pos positive.